Clinical Trial Update: Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of NeuroEPO in adults with mild to moderate Alzheimer's disease is listed as not yet recruiting, spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• NeuroEPO

Snippet

Sponsor: University of Saskatchewan | Conditions: Mild Alzheimer's Disease, Moderate Alzheimer's Disease | Phase 2 | Status: NOT_YET_RECRUITING